Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
733.51 | -45.65% | -23.35% | 654,235.43 | 0.72% | 3.59% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
886.60 | 3.46% | 24.94% | 3,864,579.71 | 1.08% | 18.25% |
|
NYSE:JNJ
Johnson & Johnson
|
146.14 | 0% | 0% | 356,431.01 | 3.38% | 3.91% |
|
NYSE:MRK
Merck
|
131.20 | -7.08% | 6.52% | 321,694.58 | 2.36% | -19.03% |
|
NYSE:ABBV
AbbVie
|
159.62 | -23.42% | -13.29% | 296,211.53 | 3.71% | 7.03% |
|
LSE:AZN
AstraZeneca PLC
|
119.88 | 19.74% | 42.63% | 186,430.79 | 2.06% | 15.98% |
|
SWX:NOVN
Novartis
|
89.50 | 13.6% | 27.68% | 181,473.74 | 3.67% | 4.67% |
|
NasdaqGS:AMGN
Amgen
|
269.98 | 1.55% | 11.74% | 144,810.67 | 3.34% | 5.31% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.85 | 59.34% | 69.53% | 90,596.11 | 5.37% | 13.54% |
|
ASX:CSL
CSL
|
273.30 | 27.29% | 48.97% | 130,231.78 | 1.3% | 7.18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.42 | 25.5% | 35.15% | 81,389.69 | 4.72% | 0.15% |
|
LSE:GSK
GSK
|
16.53 | 15.36% | 32.47% | 67,542.62 | 3.54% | 0.79% |
|
NYSE:MMM
3M
|
91.83 | 84.09% | 103.49% | 50,582.75 | 6.61% | -2.45% |
|
SWX:LONN
Lonza Group
|
527.80 | -27.63% | -12.41% | 37,702.55 | 0.78% | 0.68% |
|
NasdaqGS:MRNA
Moderna
|
107.97 | -,114.04% | -,109.69% | 38,827.82 | 0% | 0% |
|
NYSE:CTVA
Corteva
|
54.92 | 21.75% | 43.55% | 38,298.65 | 1.17% | 16.12% |
|
XTRA:BEI
Beiersdorf
|
140.50 | 4.97% | 16.78% | 30,802.02 | 0.72% | 3.11% |
|
NasdaqGS:BIIB
Biogen
|
208.90 | -3.23% | 13.94% | 29,361.43 | 0% | -10.89% |
|
CPSE:COLO B
Coloplast A/S
|
863.40 | 10.32% | 27.54% | 203,647 | 2.43% | 4.41% |
|
XTRA:BAYN
Bayer
|
27.40 | 82.28% | 100.06% | 25,862.31 | 0.41% | 1.47% |
